جست‌وجوی استاد و پژوهشگر

Rune Munck Aabenhusمشاهده پروفایل

دانشیار

• Antibiotic stewardship
• Primary care
• Epidemiology
• +۴ مورد دیگر

Rune Munck Aabenhus holds dual positions as Associate Professor at the Department of Public Health, Section of General Practice within the Faculty of Health and Medical Sciences at the University of Copenhagen, and as a Postdoc at the Research Unit for General Practice. A licensed medical doctor specializing in general practice (almen medicin), he maintains clinical expertise while conducting research focused on antibiotic consumption in primary care and strategies to reduce inappropriate antibiotic use. His research interests center on: Antibiotic stewardship in primary care settings Biomarkers of inflammation/infection (particularly C-reactive protein) as point-of-care diagnostic tools Register-based epidemiology and systematic reviews International implementation studies across Europe and Central Asia Vulnerable populations including children and elderly patients Recent publications (2023-2025) reveal consistent focus on: Point-of-care testing implementation in resource-limited settings (Kyrgyzstan) Sociodemographic drivers of antibiotic overuse in elderly Danes Optimal treatment duration for common infections like pneumonia Cross-national comparisons of antibiotic prescribing behaviors Methodological innovation in recovery metrics for respiratory infections His influential 2023 Cochrane review on biomarker-guided antibiotic prescription has generated significant policy impact with 73 Scopus citations, 3 policy citations, and Wikipedia references, demonstrating real-world clinical guideline influence. No student advising relationships or specific grant funding details were documented in the source material. His work consistently leverages multi-country collaborations, evidenced by studies across 18 European nations and partnerships in Kyrgyzstan.

• Heterogeneous Catalysis
• Sustainable Energy
• CO2 Reduction
• +۳ مورد دیگر

PD Dr. Harun Tüysüz is a Research Group Leader at the Max Planck Institute for Chemical Energy Conversion , focusing on Heterogeneous Catalysis and Sustainable Energy . His work bridges catalytic materials development with applications in solar energy harvesting, CO 2 reduction, and prebiotic chemistry. Research areas include electrochemical catalysis , perovskite materials , and abiotic chemical evolution . Recent publications highlight single-atom catalysts , high-entropy alloys , and AI-driven catalyst optimization . In 2020, he received the DECHEMA Prize for his contributions to heterogeneous catalysis. His group investigates prebiotic Krebs cycle analogs , geochemical protoenzymes , and green hydrogen production via water electrolysis. Collaborations with industry and academic partners drive innovations in catalyst synthesis , structural engineering , and environmentally sustainable processes .

Meng Wangمشاهده پروفایل

استاد

• Programming Languages
• Functional Programming
• Bidirectional Programming
• +۲ مورد دیگر

Dr. Meng Wang is a Professor at the School of Computer Science, University of Bristol, where he leads the Programming Languages Research Group. His career includes prior roles as a Lecturer at University of Kent and Assistant Professor at Chalmers University of Technology. Current Affiliation: University of Bristol Past Affiliation: University of Kent Past Affiliation: Chalmers University of Technology Research interests center on applying theoretical rigor to practical programming, with a focus on designing languages and tools for software development and testing. Key areas include: Bidirectional Programming Functional Programming Software Testing Type Systems Embedded Languages Publication trends show a strong emphasis on bidirectional programming, functional language design, and compiler techniques. His recent work explores large language model applications in code translation and formal verification of refinement types in object-oriented systems. Supervision and team leadership include mentoring 12 current PhD students and 1 Research Associate, while past mentees include notable researchers who have transitioned to industry and academic roles. He has organized workshops like VeTSS summer school and co-chaired PEPM 2024, demonstrating active community engagement.

Maria Carrollمشاهده پروفایل

دانشیار

• Bioinorganic Chemistry
• Medicinal Chemistry
• Enzyme Mimics
• +۴ مورد دیگر

Maria Carroll is an Associate Professor in the Department of Chemistry & Biochemistry at Providence College, where she contributes to both teaching and research in the chemical sciences. Her academic journey includes a Ph.D. from the University of Illinois and postdoctoral training at the University of Pennsylvania, grounding her expertise in bioinorganic and medicinal chemistry. Education: Postdoctoral Research – University of Pennsylvania Ph.D. – University of Illinois (2013) B.A. in Chemistry – Drew University (2007) Her research centers on the design and function of small molecule mimics of enzymes involved in regulating superoxide, a reactive oxygen species implicated in various diseases. This work lies at the intersection of inorganic chemistry, biochemistry, and drug development, aiming to develop novel therapeutic strategies targeting oxidative stress pathways. Maria Carroll has secured external funding for her research, demonstrating her ability to lead independent scientific projects. She served as Principal Investigator on an NIH-funded project through URI under the RI-INBRE program, titled Small Molecule Mimics of Superoxide Regulating Enzymes , which was active from May 2018 to April 2019. This grant underscores her expertise in redox biochemistry and enzyme mimicry. Scientific Awards: Dr. Carroll advises undergraduate and potentially graduate researchers in her laboratory, though specific student names are not listed. Her work contributes to advancing fundamental understanding of antioxidant enzyme systems and their synthetic analogs. Future research directions may include expanding the catalytic efficiency of these mimics and exploring their biological applications in cellular and disease models. Laboratories and Research Teams: Dr. Carroll leads a research group focused on bioinorganic synthesis and characterization, likely involving collaborations within the RI-INBRE network and regional institutions. Her lab integrates techniques from synthetic chemistry, spectroscopy, and biochemical assays to evaluate the activity of designed enzyme mimics.

• Enantioselective Catalysis
• Organic Chemistry
• Asymmetric Synthesis
• +۳ مورد دیگر

Professor Andrew D. Smith is a faculty member at the School of Chemistry , University of St Andrews, where he serves as Director of Research and leads the EPSRC CRITICAT Catalysis CDT and EaSI-CAT initiatives in collaboration with Edinburgh and Heriot-Watt Universities. He completed his D. Phil at Oxford under Prof. Steve Davies and has held academic positions at St Andrews since 2005, including Royal Society URF, Reader (2010), and Professor (2012). Research interests focus on enantioselective catalysis using NHCs and isothioureas to develop novel routes for stereodefined materials. His work combines methodology development with mechanistic studies , exploring reactive intermediates like acyl ammoniums, ammonium enolates, and ylides. Collaborations with physical organic chemists (e.g., Guy Lloyd-Jones, Paul Cheong) and industry partners (GSK, Pfizer, Syngenta) highlight the interdisciplinary and applied nature of his research. Recent publications emphasize asymmetric annulation reactions , dynamic kinetic resolution of tertiary alcohols, and flow chemistry applications . His group has commercialized the HyperBTM catalyst for industrial use. Trends show a strong emphasis on heterocyclic chemistry , stereoselectivity , and green chemistry principles. Scientific accolades include the ERC Consolidator Grant (2011) , RSC Merck Prize (2014) , RSC Charles Rees Award (2018) , and FRSE (2017) . He contributes to teaching through courses in Introductory Organic Chemistry , Mechanism in Organic Chemistry , and Asymmetric Synthesis , while mentoring 35 PhD graduates and 15 postdocs.

• Electrochemistry
• Materials Science
• Nanotechnology
• +۳ مورد دیگر

Lilian Moumaneix is a researcher at Aalto University, specializing in electrochemistry and materials science. She focuses on developing advanced nanomaterials for energy conversion and storage applications, including CO 2 reduction, hydrogen evolution, and oxygen reduction reactions. Her work combines experimental approaches with computational modeling to optimize catalyst performance and stability. Recent research trends highlight her expertise in: Synthesis of metal-supported carbon materials Surface modification of electrocatalysts Size-dependent reactivity in nanoparticle systems Nitrogen-doped graphenic foam development Ozonation effects on carbon supports Deactivation mechanisms in oxide catalysts Her publications span high-impact journals like Advanced Energy and Sustainability Research , Advanced Materials , and ChemElectroChem , emphasizing scalable solutions for sustainable energy technologies.

• Materials Science
• Machine Learning Potentials
• MXenes
• +۳ مورد دیگر

Rina Ibragimova is a Postdoctoral Researcher at Aalto University, affiliated with the DAS Group in the Chemistry and Materials domain. Her research focuses on computational materials science, particularly the development and application of machine learning interatomic potentials for modeling hydrocarbons and MXenes. Her work spans surface functionalization, defect analysis, and electronic properties of 2D materials. Recent publications highlight collaborations with leading researchers in the field, emphasizing experiment-driven atomistic modeling and theoretical studies of MXene stability and structure. Key trends in her research include combining spectroscopic data (XPS) with machine learning for precise structure inference, investigating pH-dependent functionalization in MXenes, and exploring electron beam effects on 2D materials. Her publications appear in high-impact journals like ACS Nano , Nature Communications , and Physical Review B .

• Inorganic Chemistry
• Materials Science
• Photophysics
• +۳ مورد دیگر

Toni Petteri Emil Eskelinen serves as a Postdoctoral Researcher within the Chemistry and Materials department at Aalto University, Finland. His academic profile centers on advanced photophysical materials research, with specialization in computational and experimental studies of luminescent systems. He actively contributes to the Inorganic Materials Modelling research group, focusing on molecular design for next-generation optoelectronic applications. Dr. Eskelinen's research expertise spans inorganic chemistry, materials science, and photophysics. His work encompasses transition metal complexes (Cu, Pt, Bi), organic dyes, and hybrid inorganic-organic systems. Key areas include thermally activated delayed fluorescence (TADF), room-temperature phosphorescence, and near-infrared emission mechanisms. He employs quantum chemical methods and experimental characterization to establish structure-property relationships in photofunctional materials, with emphasis on energy transfer processes and aggregation effects. Analysis of his 2022-2025 publications reveals a cohesive research trajectory centered on luminescent materials. His contributions bridge fundamental coordination chemistry with applied materials development, particularly in platinum-bismuth systems and organic ionic crystals. A significant portion involves computational benchmarking of photophysical properties, while experimental work advances understanding of through-space sensitization and solvent-dependent luminescence. These studies collectively target applications in OLEDs, bioimaging, and solid-state lighting technologies. He maintains active collaboration within Aalto University's research ecosystem and with international partners including Igor O. Koshevoy, Antti J. Karttunen, and Pi-Tai Chou, as evidenced by his co-authorship across multiple high-impact journals in inorganic and materials chemistry.

• Plasma Physics
• CO2 Conversion
• Non-equilibrium Plasmas
• +۵ مورد دیگر

Tiago Silva is an Invited Assistant Professor in the Physics Department of Instituto Superior Técnico at the University of Lisbon, Portugal, specializing in Plasma Physics, Lasers and Nuclear Fusion. He is also a Researcher at the Institute of Plasmas and Nuclear Fusion (IPFN) within the N-PRiME research group. University: University of Lisbon School: Instituto Superior Técnico Department: Physics Department Research Group: N-PRiME (N-Plasmas Reactive: Modelling and Engineering) Dr. Silva completed his MSc in Physics Engineering at Instituto Superior Técnico in 2011 and earned his PhD in Plasma Physics from the University of Mons, Belgium in 2015. His research focuses on plasma physics with particular emphasis on CO2 conversion technologies, non-equilibrium plasma kinetics, and applications for Martian resource utilization. He recently received a Fulbright Grant to conduct research at MIT on plasma technology for converting CO2 into oxygen in the Martian environment. His publication record shows a strong focus on CO2 plasma chemistry, vibrational kinetics, and plasma-catalyst interactions, with numerous high-impact publications in journals such as Plasma Sources Science and Technology, Journal of Physics D, and The Journal of Physical Chemistry A. His work demonstrates expertise in both experimental plasma characterization and computational plasma modeling. Fulbright Grant recipient for MIT research on Martian CO2 conversion Over 30 international journal publications Approximately 40 conference communications (12 invited talks) Google Scholar citations: 1,600 (h-index: 22 as of November 2024) Dr. Silva has supervised 1 PhD student and 7 MSc/Bachelor students at Instituto Superior Técnico. His research is supported by multiple grants from the European Space Agency and Fundação para a Ciência e a Tecnologia, including projects focused on CO2 conversion, plasma catalysis, and Martian resource utilization. He is actively involved in several research groups studying plasma applications for environmental technology and space exploration.

Jürgen Eversمشاهده پروفایل

استاد

• High-Pressure Materials Science
• Zintl Phases
• Crystal Structure Analysis
• +۱۳ مورد دیگر

Prof. Dr. Jürgen Evers is a distinguished Professor at the Department of Chemistry and Biochemistry, Ludwig-Maximilians-Universität München (LMU Munich) . His career spans over five decades, with pivotal contributions to high-pressure materials science , Zintl phases , and intermetallic compounds . He earned his doctorate in 1974 under Alfred Weiss and habilitated in 1982, focusing on pressure-temperature effects in disilicides and digermanides. Academic Timeline: Chemical laboratory technician (1958-1961), evening gymnasium (1962-1966), chemistry studies (Free University Berlin 1967-1968, LMU Munich 1968-1971), research at ETH Zurich (1972-1975), Heisenberg Fellowship (1984), Priv.-Doz. (1987), Associate Professor (1994), Cornell University research stay (1997). Research Focus: High-pressure synthesis and crystallography of Zintl phases (e.g., MSi 2 ), transformation of three- to four-connected networks in elements like silicon and nitrogen, and metallization under extreme conditions. His work on trivalent nitrogen networks under 5 Mbar pressure mirrors earlier Zintl phase discoveries in BaSi 2 . Scientific Awards: Recipient of the Heisenberg Fellowship (1984), reflecting his foundational role in high-pressure solid-state chemistry. Publications: Over 40 years, his 15 most recent articles (2007-2023) span molecular structures (mercury fulminate, hydrazoic acid), high-pressure phase transitions (cesium azide), reactive materials (ZrW 2 , HfW 2 ), and historical analyses (Wittelsbach Diamond, Czochralski Process). Collaborations with Thomas M. Klapötke and Gilbert Oehlinger dominate recent work. Advising: Mentored key researchers including Gerhard Sextl (Fraunhofer Institute), Bernd Sendlinger (University of Applied Management), and Gerhard Nuspl , contributing to structural studies in CeCu 2 -type compounds.

Paul J. Ragognaمشاهده پروفایل

استاد

• Inorganic Chemistry
• Main Group Chemistry
• Synthesis
• +۷ مورد دیگر

Paul J. Ragogna is a Professor and Associate Dean of Science (Research) in the Department of Chemistry at Western University. His research focuses on the chemistry of main group elements, particularly phosphorus, with applications in materials science and surface chemistry. He leads the Ragogna Group, which conducts fundamental research on novel molecular architectures and their applications for solving real-world problems. Ragogna earned his Ph.D. from Dalhousie University in 2004 and his B.Sc. (Honours) from Brock University in 2000. His work centers on discovering unusual structures and bonding in small molecule architectures, with particular emphasis on P-H bond addition chemistry to element-element multiple bonds. The Ragogna Group translates these fundamental discoveries into practical applications through surface modification techniques, creating surfaces with anti-ice, antimicrobial, superhydrophobic, or oxygen scavenging properties. His research spans multiple disciplines including inorganic chemistry, polymer science, and materials engineering. The group develops both solution-phase bulk syntheses and gas-phase processes for creating thin films (10-100 nm thickness) with specialized properties. Their work has applications across various industries including coatings, automotive, and biomedical fields. Florence Bucke Award (2018) Faculty of Science Distinguished Professor (2017) Strem Award for Pure/Applied Inorganic Chemistry (2014) University Faculty Scholar (2012) John Charles Polanyi Prize (2005) Professor Ragogna has mentored numerous graduate students, postdoctoral researchers, and undergraduate students. His group maintains collaborative relationships with other research groups and private sector partners, providing diverse research experiences. The Ragogna Group has developed expertise in UV curable coatings, surface science, and atomic layer deposition techniques, with applications ranging from icephobic surfaces to antimicrobial coatings for medical devices.

• Vascular Diseases
• Perivascular Adipose Tissue (PVAT)
• AMP-activated Protein Kinase (AMPK)
• +۵ مورد دیگر

Professor Simon Kennedy is a Professor of Vascular Pharmacology within the School of Cardiovascular & Metabolic Health at the University of Glasgow, where he has been a faculty member since 2006. He currently serves as the Senior Senate Assessor for Student Conduct and holds various administrative roles including membership on the University Court, Education Policy & Strategy Committee, Finance Committee, and Audit and Risk Committee. Additionally, he is actively involved with the British Pharmacological Society, serving on their Finance and Awards Committees, and is a member of the editorial boards of two top-ranking pharmacology journals. Professor Kennedy's primary research focuses on vascular diseases and comorbidities, with particular emphasis on the role of perivascular adipose tissue (PVAT) in vascular function. His work investigates the effects of AMP-activated protein kinase (AMPK) within PVAT and the vascular wall, the impact of hypoxia on sphingosine kinase (SK) expression and function, and the role of connexins in cell communication affecting vascular function in both pulmonary and systemic circulations. His research spans cellular signaling mechanisms and vascular structure and function. Analysis of his recent publications reveals a consistent focus on vascular pharmacology with particular emphasis on AMPK signaling pathways, perivascular adipose tissue function, and vascular responses to various stressors. His work demonstrates strong interdisciplinary collaboration across pharmacology, vascular biology, and biomedical engineering, with increasing focus on translational applications including drug-eluting stent technology and vascular monitoring systems. Professor Kennedy serves as the coordinator for Level 4 of the Pharmacology degree program and teaches various final-year options, including an in vivo skills course funded by a British Pharmacological Society teaching grant. He acts as an academic advisor to approximately 40 undergraduate students and contributes to teaching across multiple degree programs including MBChB and BDS degrees. His external academic engagements include serving as an external examiner at two Russell Group universities and as treasurer of the Scottish Cardiovascular Forum. His research is conducted through the Cellular Signalling & Mechanisms and Vascular Structure & Function research groups, where he collaborates with colleagues within the School of Cardiovascular & Metabolic Health, College of Science and Engineering, and external partners. His work bridges basic science with clinical applications, particularly in understanding vascular pathophysiology and developing therapeutic approaches for vascular diseases.

John Sandersonمشاهده پروفایل

دانشیار

• Biophysical Chemistry
• Biological Membranes
• Protein-Membrane Interactions
• +۵ مورد دیگر

Dr. John Sanderson is an Associate Professor in the Department of Chemistry at Durham University. His research spans biophysical chemistry, biological membranes, and protein-membrane interactions, with a focus on membrane-active peptides and lipids. He is a committee member of the British Biophysical Society and a member of the Biophysical Society (US) and the Royal Society of Chemistry (MRSC). Key Research Areas: Biophysical Chemistry, Biological Membranes, Protein-Membrane Interactions, Membrane Reactivity, Chemical Biology, Amino Acid and Peptide Synthesis, Drug-Lipid Interactions, Spectroscopy and Microscopy Techniques. Dr. Sanderson's work investigates the intrinsic reactivity of membrane lipids and their interactions with peptides, proteins, and small molecules. Recent studies include the discovery of acyl transfer reactions in lipid membranes and the development of the "amyloid lipidation hypothesis," linking lipidation to neurodegenerative diseases. His group also explores antimicrobial peptides and their clinical applications. Recent publications highlight trends in membrane reactivity, lipid-peptide interactions, and their implications in cell biology and disease. Notable works include studies on foliar amino acid biostimulants, lipidation of aquaporin-0, and the design of peptides for membrane poration. Scientific Contributions: Committee member, British Biophysical Society (2000) Member, Biophysical Society (US) and Royal Society of Chemistry (MRSC) Dr. Sanderson's group has secured funding from an EPSRC Programme Grant to study protein-membrane interactions. He supervises research students including Beth Henderson, Eoin Kearney, and Yufeng Liu, and collaborates with colleagues like Prof. R. A. Quinlan and Dr. R. P. Yeo. Labs & Teams: Sanderson Group, Department of Chemistry, Durham University

• Medicinal Chemistry
• Synthetic Chemistry
• Drug Discovery
• +۵ مورد دیگر

Dr Heulyn Jones is a Lecturer in Chemistry at Cardiff University's School of Chemistry and works at the Medicines Discovery Institute (MDI). Sponsored by the Coleg Cymraeg Cenedlaethol, Dr Jones contributes significantly to both teaching and research activities within the chemistry department. As an active researcher, Dr Jones leads projects focused on developing novel therapeutic approaches for unmet clinical needs, particularly in the areas of lysosomal storage disorders and CNS-related conditions. MChem in Chemistry from Cardiff University PhD in Chemistry from Cardiff University (2013) Postdoctoral research at University of Strathclyde (2016-2018) Research position at University of Manchester (2016) Current position at Cardiff University's Medicines Discovery Institute (2018-present) Dr Jones's research spans the boundary between chemistry and biology, with a focus on developing small molecule therapeutics. Key interests include using synthetic chemistry in conjunction with medicinal chemistry principles to improve the properties of small molecules from initial 'hits' to more suitable drug candidates. Dr Jones is particularly fascinated by bifunctional molecules like PROTACs and has growing interests in diseases caused by protein misfolding. Current research projects include small molecule inhibition of acid ceramidase (funded by LifeArc and Action Medical Research), development of novel fluorescent probes for VATP-ase (MRC-funded), and research on additional lysosomal targets and protein degradation strategies. Analysis of Dr Jones's recent publications (2016-2025) reveals a strong focus on medicinal chemistry approaches to neurological and metabolic disorders. The research demonstrates expertise in kinase inhibitors (particularly LIMK inhibitors for fragile X syndrome), lysosomal storage disorders, and innovative approaches to protein degradation. There's a clear progression from fundamental synthetic chemistry techniques toward increasingly complex biological applications, with recent work emphasizing CNS-targeted therapies and novel therapeutic modalities like PROTACs. Dr Jones has contributed to multiple patent applications related to GABA alpha 5 negative allosteric modulators and kinase inhibitors. These include UK patent application 2201949.1 (filed 2022), UK patent application 2106385.4 (filed 2021), and international patents PCT/GB2020/052423 and WO2019220101 related to CaMK1D kinase inhibitors. As a lecturer, Dr Jones supervises postgraduate students and teaches several core chemistry courses including CH5103 (Foundations of Organic Chemistry), CH5203 (Further Organic and Biological Chemistry), CH5108 (Introduction to University Chemistry), and CH5110 (Year 1 Chemistry Foundation Practical). Dr Jones also contributes to courses on communicating chemistry, biochemistry, and final year projects. Research funding includes support from Wellcome Trust, MRC, LifeArc, Action Medical Research, and the Coleg Cymraeg Cenedlaethol. Dr Jones is a key member of the Medicines Discovery Institute at Cardiff University, collaborating with researchers including Prof Simon Ward, Prof Emyr Lloyd Evans, Dr Helen Waller-Evans, Prof Awen Gallimore, Dr Niek Buurma, and Dr Katherine Smith. The research environment fosters multidisciplinary approaches to drug discovery, with particular emphasis on translating chemical innovations into potential therapeutic applications for challenging medical conditions.

Hendrik Zipseمشاهده پروفایل

استاد

• Organic Chemistry
• Radical Chemistry
• Theoretical Chemistry
• +۳ مورد دیگر

Prof. Dr. Hendrik Zipse is a faculty member in the Faculty of Chemistry and Pharmacy at Ludwig Maximilian University of Munich (LMU), where he leads research in radical chemistry and organic reaction mechanisms. His work focuses on the SFB 1309 project C03 – Oxidative lesions of modified nucleotide bases , involving synthesis of 15N-labeled nucleotides and oxidation studies. He has authored the textbook Reactivity and Mechanism in Organic Chemistry (2nd ed., 2023) and contributes to teaching graduate and PhD courses on radical chemistry, computational methods, and organic synthesis. His research integrates theoretical modeling with experimental protocols, emphasizing radical stability, hydrogen abstraction, and oxidation dynamics. Key themes: radical stability, oxidation mechanisms, computational modeling Recent monograph: Reactivity and Mechanism in Organic Chemistry (2nd ed., RSC 2023) Teaching: Computational Chemistry, Radicals in Chemistry and Biology